kringle-pharmaCo., Ltd.

NEWS

notice

Feb 14, 2005 Notice

Kringle Pharma concluded a research and evaluation agreement with GaleniSearch Laboratories to develop time-release microsphere formulations based on NK4, HGF, and other related compounds.

Kringle Pharma concluded a research and evaluation agreement with GaleniSearch Laboratories to develop time-release microsphere formulations based on NK4, HGF, and other related compounds.